23andMe cofounder Linda Avey is taking crowdsourced patient experiences to the web with a soft July launch of a platform called Curious.
Praised for helping navigate the shift by advertisers into digital, media vet Kim Kadlec is leaving pharma for a new role at AOL.
A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
The manufacturer of the so-called "Botox for eyelashes" found the majority of women it surveyed were worried about thinning fringe.
The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.
Express Scripts notes that these prescriptions may not, in fact, be for ADHD.
The NYT reports that the data on gaming long-term memory is inconclusive.
The Mario Bros. company says health and fun are the way of the future.
The company said it used "inappropriate expressions" in promotions of a blood pressure medication.
The publisher aims to bring patient stories to life through long-form multimedia narratives.
The National Association of Boards of Pharmacy says about 97% of surveyed pharmacy sites fail to comply with laws.
GoQii seeks to convert tracked calories, steps and distance into a philanthropic device.
Movable Ink reports that 65% of Q4 emails were opened on a tablet or smartphone.
TapTrak seeks to apply behavioral tracking to clinical trials.
Pharma has reduced the burden of disease. It can develop a condition-specific app. But getting people to take their medications as prescribed? That's another matter. Larry Dobrow on why biopharma is backing mobile games for their potential to boost adherence and drive behavior change
The latest IMS report shows that 50% of the top 50 pharma companies are not on social media. Executive Director Murray Aitken tells MM&M it is to pharma's detriment.
HHS has bought airtime in markets with high numbers of uninsured patients.
Chronic disease patients seek online support and information, and show little love for branded websites.
Spectrum DNA says its genetic services are at the ready, even if 23andMe's are not.
The drugmaker now owns the @Pfizer handle in addition to @Pfizer_news
The Kaiser Family Foundation's just-launched website, funded by Gilead, addresses healthcare reform from a distinct perspective.
The drugmaker says 20 jobs, or 17% of its workforce, will be gone by the end of the year.
They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.
The voice-activated app costs 99 cents.
Researchers found that most healthcare apps have limited functionality, don't serve patients with multiple needs, and taper off when support is needed most. No wonder adoption is low.
The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.
Smartphone users, while in the exam room, are more apt to be in "switch mentality," a study finds.
The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.
An upcoming leadership summit is devoted to exploring whether health social media is driving meaningful change, as well as new ways to engage with health activists.
The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.